Ignite Creation Date:
2025-12-24 @ 3:31 PM
Ignite Modification Date:
2026-01-18 @ 8:03 PM
Study NCT ID:
NCT00496392
Status:
COMPLETED
Last Update Posted:
2012-05-07
First Post:
2007-07-03
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Comparison of Nasal Fentanyl and Oral Transmucosal Fentanyl (Actiq) in Cancer Breakthrough Pain (FT-019-IM)
Sponsor:
Nycomed
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
FT-019-IM
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Nycomed
Old Organization:
Nycomed